A detailed history of Stifel Financial Corp transactions in Uni Qure N.V. stock. As of the latest transaction made, Stifel Financial Corp holds 60,996 shares of QURE stock, worth $434,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,996
Previous 63,040 3.24%
Holding current value
$434,901
Previous $282,000 6.38%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.78 - $10.12 $7,726 - $20,685
-2,044 Reduced 3.24%
60,996 $300,000
Q2 2024

Aug 13, 2024

BUY
$4.39 - $5.43 $173,514 - $214,620
39,525 Added 168.08%
63,040 $282,000
Q1 2024

May 13, 2024

BUY
$4.82 - $6.93 $1,378 - $1,981
286 Added 1.23%
23,515 $122,000
Q4 2023

Feb 12, 2024

SELL
$5.63 - $8.27 $7,679 - $11,280
-1,364 Reduced 5.55%
23,229 $157,000
Q3 2023

Nov 13, 2023

BUY
$6.71 - $11.83 $2,200 - $3,880
328 Added 1.35%
24,593 $165,000
Q2 2023

Aug 14, 2023

BUY
$11.12 - $22.2 $102,693 - $205,017
9,235 Added 61.44%
24,265 $278,000
Q1 2023

May 12, 2023

BUY
$18.7 - $23.07 $2,973 - $3,668
159 Added 1.07%
15,030 $302,000
Q4 2022

Feb 13, 2023

BUY
$18.12 - $27.32 $269,462 - $406,275
14,871 New
14,871 $337,000
Q3 2021

Nov 15, 2021

SELL
$26.01 - $38.22 $183,526 - $269,680
-7,056 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$29.97 - $37.17 $211,468 - $262,271
7,056 New
7,056 $217,000
Q4 2020

Feb 12, 2021

SELL
$35.35 - $50.67 $217,331 - $311,519
-6,148 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$35.98 - $47.66 $221,205 - $293,013
6,148 New
6,148 $226,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $333M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.